Skip to main content
Top
Published in: European Radiology 8/2014

01-08-2014 | Nuclear Medicine

Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak

Authors: E. Laffon, F. Lamare, H. de Clermont, I. A. Burger, R. Marthan

Published in: European Radiology | Issue 8/2014

Login to get access

Abstract

Objectives

To assess variability of the average standard uptake value (SUV) computed by varying the number of hottest voxels within an 18F-fluorodeoxyglucose (18F-FDG)-positive lesion. This SUV metric was compared with the maximal SUV (SUVmax: the hottest voxel) and peak SUV (SUVpeak: SUVmax and its 26 neighbouring voxels).

Methods

Twelve lung cancer patients (20 lesions) were analysed using PET dynamic acquisition involving ten successive 2.5-min frames. In each frame and lesion, average SUV obtained from the N = 5, 10, 15, 20, 25 or 30 hottest voxels (SUVmax–N ), SUVmax and SUVpeak were assessed. The relative standard deviations (SDrs) from ten frames were calculated for each SUV metric and lesion, yielding the mean relative SD from 20 lesions for each SUV metric (SDr N , SDrmax and SDrpeak), and hence relative measurement error and repeatability (MEr–R).

Results

For each N, SDr N was significantly lower than SDrmax and SDrpeak. SDr N correlated strongly with N: 6.471 × N -0.103 (r = 0.994; P < 0.01). MEr–R of SUVmax-30 was 8.94–12.63 % (95 % CL), versus 13.86–19.59 % and 13.41–18.95 % for SUVmax and SUVpeak respectively.

Conclusions

Variability of SUVmax–N is significantly lower than for SUVmax and SUVpeak. Further prospective studies should be performed to determine the optimal total hottest volume, as voxel volume may depend on the PET system.

Key Points

PET imaging provides functional parameters of 18 F-FDG-positive lesions, such as SUVmax and SUVpeak.
Averaging SUV from several hottest voxels (SUVmax- N ) is a further SUV metric.
Variability of SUVmax– N is significantly lower than SUVmax and SUVpeak variability.
SUVmax– N should improve SUV accuracy for predicting outcome or assessing treatment response.
An optimal total hottest volume should be determined through further prospective studies.
Literature
1.
2.
go back to reference Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50:11S–20SPubMedCrossRef Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50:11S–20SPubMedCrossRef
3.
go back to reference Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11:2101–2111PubMed Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11:2101–2111PubMed
4.
go back to reference Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumours. J Nucl Med 50:122S–150SPubMedCentralPubMedCrossRef Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumours. J Nucl Med 50:122S–150SPubMedCentralPubMedCrossRef
5.
go back to reference Visser EP, Boerman OC, Oyen WJG (2010) SUV: from silly useless value to smart uptake value. J Nucl Med 51:173–175PubMedCrossRef Visser EP, Boerman OC, Oyen WJG (2010) SUV: from silly useless value to smart uptake value. J Nucl Med 51:173–175PubMedCrossRef
6.
go back to reference Tylski P, Stute S, Grotus N et al (2010) Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET. J Nucl Med 51:268–276PubMedCrossRef Tylski P, Stute S, Grotus N et al (2010) Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET. J Nucl Med 51:268–276PubMedCrossRef
7.
go back to reference Vanderhoek M, Perlman SB, Jeraj R (2012) Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med 53:4–11PubMedCentralPubMedCrossRef Vanderhoek M, Perlman SB, Jeraj R (2012) Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med 53:4–11PubMedCentralPubMedCrossRef
8.
go back to reference Burger IA, Huser DM, Burger C, von Schulthess GK, Buck A (2012) Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax. Nucl Med Biol 39:666–670PubMedCrossRef Burger IA, Huser DM, Burger C, von Schulthess GK, Buck A (2012) Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax. Nucl Med Biol 39:666–670PubMedCrossRef
9.
go back to reference Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-Le Rest D (2011) Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging 38:1191–1202PubMedCrossRef Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-Le Rest D (2011) Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging 38:1191–1202PubMedCrossRef
10.
go back to reference Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945PubMedCrossRef Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945PubMedCrossRef
13.
go back to reference Boellaard R, O’Doherty MJ, Weber WA et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37:181–200PubMedCentralPubMedCrossRef Boellaard R, O’Doherty MJ, Weber WA et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37:181–200PubMedCentralPubMedCrossRef
14.
go back to reference Tixier F, Hatt M, Le Rest CC, Le Pogam A, Corcos L, Visvikis D (2012) Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53:693–700PubMedCentralPubMedCrossRef Tixier F, Hatt M, Le Rest CC, Le Pogam A, Corcos L, Visvikis D (2012) Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53:693–700PubMedCentralPubMedCrossRef
15.
go back to reference Hatt M, Tixier F, Cheze Le Rest C, Pradier O, Visvikis D (2013) Robustness of intratumour F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40:1662–1671PubMedCrossRef Hatt M, Tixier F, Cheze Le Rest C, Pradier O, Visvikis D (2013) Robustness of intratumour F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40:1662–1671PubMedCrossRef
16.
go back to reference Larson SM, Erdi Y, Akhurst T et al (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2:159–171PubMedCrossRef Larson SM, Erdi Y, Akhurst T et al (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2:159–171PubMedCrossRef
17.
go back to reference Chen HH, Chiu NT, Su WC, Guo HR, Lee BF (2012) Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology 264:559–566PubMedCrossRef Chen HH, Chiu NT, Su WC, Guo HR, Lee BF (2012) Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology 264:559–566PubMedCrossRef
18.
go back to reference Soussan M, Chouahnia K, Maisonobe J-A et al (2013) Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy. Eur J Nucl Med Mol Imaging 40:668–676PubMedCrossRef Soussan M, Chouahnia K, Maisonobe J-A et al (2013) Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy. Eur J Nucl Med Mol Imaging 40:668–676PubMedCrossRef
19.
go back to reference Scheffler M, Zander T, Nogova L et al (2013) Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib. PLoS ONE 8:e53081PubMedCentralPubMedCrossRef Scheffler M, Zander T, Nogova L et al (2013) Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib. PLoS ONE 8:e53081PubMedCentralPubMedCrossRef
20.
go back to reference Laffon E, de Clermont H, Lamare F, Marthan R (2013) Variability of total lesion glycolysis by 18FDG-positive tissue thresholding in lung cancer. J Nucl Med Technol 41:186–191PubMedCrossRef Laffon E, de Clermont H, Lamare F, Marthan R (2013) Variability of total lesion glycolysis by 18FDG-positive tissue thresholding in lung cancer. J Nucl Med Technol 41:186–191PubMedCrossRef
21.
go back to reference Lambin P, Roelofs E, Reymen B et al (2013) Rapid learning health care in oncology—an approach towards decision support systems enabling customised radiotherapy. Radiother Oncol 109:159–164PubMedCrossRef Lambin P, Roelofs E, Reymen B et al (2013) Rapid learning health care in oncology—an approach towards decision support systems enabling customised radiotherapy. Radiother Oncol 109:159–164PubMedCrossRef
22.
go back to reference Ambrosini V, Nicolini S, Caroli P (2012) PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol 81:988–1001PubMedCrossRef Ambrosini V, Nicolini S, Caroli P (2012) PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol 81:988–1001PubMedCrossRef
23.
go back to reference Laffon E, de Clermont H, Marthan R (2013) Variability of (18)F-FDG-positive lung lesion volume by thresholding. Eur Radiol 23:1131–1137PubMedCrossRef Laffon E, de Clermont H, Marthan R (2013) Variability of (18)F-FDG-positive lung lesion volume by thresholding. Eur Radiol 23:1131–1137PubMedCrossRef
24.
go back to reference Boellaard R (2011) Need for standardization of 18F-FDG PET/CT for treatment response assessments. J Nucl Med 52:93S–100SPubMedCrossRef Boellaard R (2011) Need for standardization of 18F-FDG PET/CT for treatment response assessments. J Nucl Med 52:93S–100SPubMedCrossRef
25.
go back to reference de Langen AJ, Vincent A, Velasquez LM et al (2012) Repeatability of 18F-FDG uptake measurements in tumors: a meta-analysis. J Nucl Med 53:701–708PubMedCrossRef de Langen AJ, Vincent A, Velasquez LM et al (2012) Repeatability of 18F-FDG uptake measurements in tumors: a meta-analysis. J Nucl Med 53:701–708PubMedCrossRef
Metadata
Title
Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak
Authors
E. Laffon
F. Lamare
H. de Clermont
I. A. Burger
R. Marthan
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3222-x

Other articles of this Issue 8/2014

European Radiology 8/2014 Go to the issue